Clinical Trial Update: Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment. [NA]

View source ↗

Summary

Completed trial evaluating eye injections of bevacizumab to reduce scar tissue in the retina and prevent recurrent retinal detachment. Results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Vitreoretinopathy
• Retinal Detachment

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Wills Eye | Conditions: Retinal Detachment, Vitreoretinopathy Proliferative | NA | Status: COMPLETED | Results posted: 2017-04-17